<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2007-4832</journal-id>
<journal-title><![CDATA[Acta de investigación psicológica]]></journal-title>
<abbrev-journal-title><![CDATA[Acta de investigación psicol]]></abbrev-journal-title>
<issn>2007-4832</issn>
<publisher>
<publisher-name><![CDATA[Universidad Nacional Autónoma de México, Facultad de Psicología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2007-48322021000100016</article-id>
<article-id pub-id-type="doi">10.22201/fpsi.20074719e.2021.1.370</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[La Administración del Agonista mGluR2/3 APDC Disminuye la Señal Discriminativa de la Anfetamina en Ratas]]></article-title>
<article-title xml:lang="en"><![CDATA[Administration of the mGluR2/3 APDC Decreases the Discriminative Signal of Amphetamine in Rats]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cedillo Zavaleta]]></surname>
<given-names><![CDATA[Laura N.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jiménez Mejía]]></surname>
<given-names><![CDATA[Juan C.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ruiz-García]]></surname>
<given-names><![CDATA[Rosa Isela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Miranda]]></surname>
<given-names><![CDATA[Florencio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Nacional Autónoma de México Facultad de Estudios Superiores ]]></institution>
<addr-line><![CDATA[Iztacala ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2021</year>
</pub-date>
<volume>11</volume>
<numero>1</numero>
<fpage>16</fpage>
<lpage>26</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2007-48322021000100016&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2007-48322021000100016&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2007-48322021000100016&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen Los efectos reforzantes, motores y discriminativos de la anfetamina (ANF) están mediados por el incremento en la neurotransmisión de dopamina (DA) en el núcleo accumbens. Existe evidencia de que el sistema Gluérgico podría regular la función DAérgica. Aquí, se examina el papel de los receptores mGluR2/3 en las propiedades discriminativas de la ANF usando el condicionamiento de aversión a los sabores (CAS). Ratas macho de la cepa Wistar fueron privadas de agua y entrenadas con el CAS. Se les administró ANF (1.0 mg/kg ip) antes de un periodo de acceso de 10 min a una solución de sacarina y posteriormente se les administró una inyección de LiCl; en días alternos, se les aplicó una inyección de salina (1 ml/kg ip) antes y después del acceso a la solución de sacarina. En las pruebas de generalización y combinación, la ANF fue substituida por diferentes dosis del agonista mGluR2/3 (2R,4R)-APDC (0.1, 0.3 y 1.0 mg/kg ip), diferentes dosis del antagonista mGluR2/3 LY341495 (1.0, 3.0 y 5.6 mg/kg ip), diferentes dosis de APDC (0.1, 0.3 y 1.0 mg/kg ip) + ANF (1 ml/kg ip) o diferentes dosis de LY341495 (1.0, 3.0 y 5.6 mg/kg ip) + APDC (1.0 mg/kg ip) + ANF (1.0 mg/kg ip). Los resultados mostraron que el agonista APDC disminuyó la señal discriminativa de la ANF y este efecto fue prevenido por el antagonista LY341495. Se sugiere que los receptores mGluR2/3 podrían jugar un papel modulatorio en la señal discriminativa de la ANF.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Rewarding, motor and discriminative effects of amphetamine (AMPH) are mediated in large part by increased dopamine (DA) neurotransmission in the nucleus accumbens. However, there is evidence that the glutamate system may regulate forebrain DA function. Here, we examined the role of mGluR2/3 receptors on the discriminative stimulus properties of AMPH using conditioned taste aversion (CTA) as the drug discrimination procedure. Male Wistar rats were deprived of water and trained in the CTA procedure. They received the administration of AMPH (1.0 mg/kg) before a 10 min period of access to saccharin solution and followed by an injection of LiCl; on alternate days, rats received saline (1 ml/kg ip) before and after the access to saccharin solution. In generalization and combination tests, the AMPH was substituted by different doses of the mGluR2/3 receptor agonist (2R,4R)-APDC (0.1, 0.3 and 1.0 mg/kg ip), different doses of the mRGlu2/3 receptor antagonist LY341495 (1.0, 3.0 and 5.6 mg/kg ip), different doses of the mGluR2/3 receptor agonist APDC (0.1, 0.3 y 1.0 mg/kg ip) + AMPH (1.0 mg/kg ip) or different doses of the mGluR2/3 receptor antagonist LY341495 (1.0, 3.0 and 5.6 mg/kg ip) + APDC (1.0 mg/kg ip) + AMPH (1.0 mg/kg ip). The results showed that the agonist APDC significantly decreases the discriminative cue of the AMPH and this effect was reversed by the antagonist LY341495. These data suggest that mGluR2/3 receptors could play an important modulatory role in the discriminative cue of AMPH.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Anfetamina]]></kwd>
<kwd lng="es"><![CDATA[Discriminación de Drogas]]></kwd>
<kwd lng="es"><![CDATA[Receptores mGluR2/3]]></kwd>
<kwd lng="es"><![CDATA[Condicionamiento de Aversión a los Sabores]]></kwd>
<kwd lng="es"><![CDATA[Dopamina]]></kwd>
<kwd lng="en"><![CDATA[Amphetamine]]></kwd>
<kwd lng="en"><![CDATA[Drug Discrimination]]></kwd>
<kwd lng="en"><![CDATA[mGluR2/3 Receptors]]></kwd>
<kwd lng="en"><![CDATA[Conditioned Test Aversion]]></kwd>
<kwd lng="en"><![CDATA[Dopamine]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Acosta-García]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[J. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Miranda]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Additive Effects of Coadministration of A 2A Receptor Agonist CGS-21680and mGluR5 Antagonist MPEP on the Development and Expression of Methamphetamine-Induced Locomotor Sensitization in Rats]]></article-title>
<source><![CDATA[Journal of Drug and Alcohol Research]]></source>
<year>2017</year>
<volume>6</volume>
<page-range>1-11</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arndt]]></surname>
<given-names><![CDATA[D. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Arnold]]></surname>
<given-names><![CDATA[J. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Cain]]></surname>
<given-names><![CDATA[M. E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effects of mGluR2/3 activation on acute and repeated amphetamine-induced locomotor activity in differentially reared male rats]]></article-title>
<source><![CDATA[Experimental and Clinical Psychopharmacology]]></source>
<year>2014</year>
<volume>22</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>257-65</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Augier]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Dulman]]></surname>
<given-names><![CDATA[R. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Rauffenbart]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Augier]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Cross]]></surname>
<given-names><![CDATA[A. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Heilig]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The mGluR2 Positive Allosteric Modulator, AZD8529, and Cue-Induced Relapse to Alcohol Seeking in Rats]]></article-title>
<source><![CDATA[Neuropsychopharmacology]]></source>
<year>2016</year>
<volume>41</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>2932-40</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baptista]]></surname>
<given-names><![CDATA[M. A. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Martin-Fardon]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Weiss]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Preferential Effects of the Metabotropic Glutamate 2/3 Receptor Agonist LY379268 on Conditioned Reinstatement versus Primary Reinforcement: Comparison between Cocaine and a Potent Conventional Reinforcer]]></article-title>
<source><![CDATA[Journal of Neuroscience]]></source>
<year>2004</year>
<volume>24</volume>
<numero>20</numero>
<issue>20</issue>
<page-range>4723-7</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bossert]]></surname>
<given-names><![CDATA[J. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[S. Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Lu]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Shaham]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Role of Ventral Tegmental Area Glutamate in Contextual Cue-Induced Relapse to Heroin Seeking]]></article-title>
<source><![CDATA[Journal of Neuroscience]]></source>
<year>2004</year>
<volume>24</volume>
<numero>47</numero>
<issue>47</issue>
<page-range>10726-30</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cannella]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Halbout]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Uhrig]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Evrard]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Corsi]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Corti]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Deroche-Gamonet]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Hansson]]></surname>
<given-names><![CDATA[A. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Spanagel]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The mGluR2/3 Agonist LY379268 Induced Anti-Reinstatement Effects in Rats Exhibiting Addiction-like Behavior]]></article-title>
<source><![CDATA[Neuropsychopharmacology]]></source>
<year>2013</year>
<volume>38</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>2048-56</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cartmell]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Monn]]></surname>
<given-names><![CDATA[J. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Schoepp]]></surname>
<given-names><![CDATA[D. D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268]]></article-title>
<source><![CDATA[Naunyn-Schmiedeberg&#8217;s Archives of Pharmacology]]></source>
<year>2000</year>
<volume>361</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>39-46</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cedillo]]></surname>
<given-names><![CDATA[L. N.]]></given-names>
</name>
<name>
<surname><![CDATA[Miranda]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of co-administration of the GABAB receptor agonist baclofen and a positive allosteric modulator of the GABAB receptor, CGP7930, on the development and expression of amphetamineinduced locomotor sensitization in rats]]></article-title>
<source><![CDATA[Pharmacological Reports]]></source>
<year>2013</year>
<volume>65</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1132-43</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cedillo]]></surname>
<given-names><![CDATA[L. N.]]></given-names>
</name>
<name>
<surname><![CDATA[Ruíz-García]]></surname>
<given-names><![CDATA[R. I.]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[J. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Miranda]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of coadministration of the GABAB agonist baclofen and the 5-HT2C agonist Ro60-0175 on the expression of amphetamine-induced locomotor sensitization]]></article-title>
<source><![CDATA[Experimental Brain Research]]></source>
<year>2019</year>
<volume>237</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1691-7</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clark]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[B. G.]]></given-names>
</name>
<name>
<surname><![CDATA[Wright]]></surname>
<given-names><![CDATA[R. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Monn]]></surname>
<given-names><![CDATA[J. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Schoepp]]></surname>
<given-names><![CDATA[D. D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of the mGlu2/3 receptor agonist LY379268 on motor activity in phencyclidine-sensitized rats]]></article-title>
<source><![CDATA[Pharmacology Biochemistry and Behavior]]></source>
<year>2002</year>
<volume>73</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>339-46</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Coutinho]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Knöpfel]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Book Review: Metabotropic Glutamate Receptors: Electrical and Chemical Signaling Properties]]></article-title>
<source><![CDATA[The Neuroscientist]]></source>
<year>2002</year>
<volume>8</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Crawford]]></surname>
<given-names><![CDATA[J. T.]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[D. C. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Beveridge]]></surname>
<given-names><![CDATA[T. J. R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The group II metabotropic glutamate receptor agonist, LY379268, decreases methamphetamine self-administration in rats]]></article-title>
<source><![CDATA[Drug and Alcohol Dependence]]></source>
<year>2013</year>
<volume>132</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>414-9</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cross]]></surname>
<given-names><![CDATA[A. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Anthenelli]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[X.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabotropic Glutamate Receptors 2 and 3 as Targets for Treating Nicotine Addiction]]></article-title>
<source><![CDATA[Biological Psychiatry]]></source>
<year>2018</year>
<volume>83</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>947-54</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Di Chiara]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of dopamine in drug abuse viewed from the perspective of its role in motivation]]></article-title>
<source><![CDATA[Drug and Alcohol Dependence]]></source>
<year>1995</year>
<volume>38</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>95-137</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dietrich]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Kral]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Clusmann]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Friedl]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Schramm]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Presynaptic group II metabotropic glutamate receptors reduce stimulated and spontaneous transmitter release in human dentate gyrus]]></article-title>
<source><![CDATA[Neuropharmacology]]></source>
<year>2002</year>
<volume>42</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>297-305</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Elliott]]></surname>
<given-names><![CDATA[J. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Beveridge]]></surname>
<given-names><![CDATA[T. J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Psychostimulants and monoamine transporters: Upsetting the balance]]></article-title>
<source><![CDATA[Current Opinion in Pharmacology]]></source>
<year>2005</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>94-100</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Faraone]]></surname>
<given-names><![CDATA[S. V.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities]]></article-title>
<source><![CDATA[Neuroscience &amp; Biobehavioral Reviews]]></source>
<year>2018</year>
<volume>87</volume>
<page-range>255-70</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fischer]]></surname>
<given-names><![CDATA[K. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Knackstedt]]></surname>
<given-names><![CDATA[L. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Rosenberg]]></surname>
<given-names><![CDATA[P. A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Glutamate homeostasis and dopamine signaling: Implications for psychostimulant addiction behavior]]></article-title>
<source><![CDATA[Neurochemistry International]]></source>
<year>2021</year>
<volume>144</volume>
<page-range>104896</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Herrera]]></surname>
<given-names><![CDATA[F. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Velazquez Martinez]]></surname>
<given-names><![CDATA[D. N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Discriminative stimulus properties of amphetamine in a conditioned taste aversion paradigm]]></article-title>
<source><![CDATA[Behavioural Pharmacology]]></source>
<year>1997</year>
<volume>8</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>458-64</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ishiguro]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Miyake]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Tabata]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Mochizuki]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Sakurai]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Onaivi]]></surname>
<given-names><![CDATA[E. S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neuronal cell adhesion molecule regulating neural systems underlying addiction]]></article-title>
<source><![CDATA[Neuropsychopharmacology Reports]]></source>
<year>2019</year>
<volume>39</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>10-6</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Justinova]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Le Foll]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Redhi]]></surname>
<given-names><![CDATA[G. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Markou]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Goldberg]]></surname>
<given-names><![CDATA[S. R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Differential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on nicotine versus cocaine self-administration and relapse in squirrel monkeys]]></article-title>
<source><![CDATA[Psychopharmacology]]></source>
<year>2016</year>
<volume>233</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1791-800</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Justinova]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Panlilio]]></surname>
<given-names><![CDATA[L. V.]]></given-names>
</name>
<name>
<surname><![CDATA[Secci]]></surname>
<given-names><![CDATA[M. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Redhi]]></surname>
<given-names><![CDATA[G. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Schindler]]></surname>
<given-names><![CDATA[C. W.]]></given-names>
</name>
<name>
<surname><![CDATA[Cross]]></surname>
<given-names><![CDATA[A. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Mrzljak]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Medd]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Shaham]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Goldberg]]></surname>
<given-names><![CDATA[S. R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Novel Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator, AZD8529, Decreases Nicotine Self-Administration and Relapse in Squirrel Monkeys]]></article-title>
<source><![CDATA[Biological Psychiatry]]></source>
<year>2015</year>
<volume>78</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>452-62</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Karkhanis]]></surname>
<given-names><![CDATA[A. N.]]></given-names>
</name>
<name>
<surname><![CDATA[Beveridge]]></surname>
<given-names><![CDATA[T. J. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Blough]]></surname>
<given-names><![CDATA[B. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[S. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Ferris]]></surname>
<given-names><![CDATA[M. J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The individual and combined effects of phenmetrazine and mgluR2/3 agonist LY379268 on the motivation to self-administer cocaine]]></article-title>
<source><![CDATA[Drug and Alcohol Dependence]]></source>
<year>2016</year>
<volume>166</volume>
<page-range>51-60</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[J. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Vezina]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The mGlu2/3 receptor agonist LY379268 blocks the expression of locomotor sensitization by amphetamine]]></article-title>
<source><![CDATA[Pharmacology Biochemistry and Behavior]]></source>
<year>2002</year>
<volume>73</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>333-7</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Koob]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Bloom]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cellular and molecular mechanisms of drug dependence]]></article-title>
<source><![CDATA[Science]]></source>
<year>1988</year>
<volume>242</volume>
<numero>4879</numero>
<issue>4879</issue>
<page-range>715-23</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Koob]]></surname>
<given-names><![CDATA[G. F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Drugs of abuse: Anatomy, pharmacology and function of reward pathways]]></article-title>
<source><![CDATA[Trends in Pharmacological Sciences]]></source>
<year>1992</year>
<volume>13</volume>
<page-range>177-84</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Koob]]></surname>
<given-names><![CDATA[G. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Volkow]]></surname>
<given-names><![CDATA[N. D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neurobiology of addiction: A neurocircuitry analysis]]></article-title>
<source><![CDATA[The Lancet Psychiatry]]></source>
<year>2016</year>
<volume>3</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>760-73</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kufahl]]></surname>
<given-names><![CDATA[P. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Watterson]]></surname>
<given-names><![CDATA[L. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Nemirovsky]]></surname>
<given-names><![CDATA[N. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Hood]]></surname>
<given-names><![CDATA[L. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Villa]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Halstengard]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Zautra]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Foster Olive]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Attenuation of methamphetamine seeking by the mGluR2/3 agonist LY379268 in rats with histories of restricted and escalated self-administration]]></article-title>
<source><![CDATA[Neuropharmacology]]></source>
<year>2013</year>
<volume>66</volume>
<page-range>290-301</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liechti]]></surname>
<given-names><![CDATA[M. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Lhuillier]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Kaupmann]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Markou]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabotropic Glutamate 2/3 Receptors in the Ventral Tegmental Area and the Nucleus Accumbens Shell Are Involved in Behaviors Relating to Nicotine Dependence]]></article-title>
<source><![CDATA[Journal of Neuroscience]]></source>
<year>2007</year>
<volume>27</volume>
<numero>34</numero>
<issue>34</issue>
<page-range>9077-85</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martin-Fardon]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Weiss]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[(-)-2-oxa-4-aminobicylco [3.1.0] hexane-4,6-dicarboxylic acid (LY379268) and 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl] piperidine (MTEP) similarly attenuate stress-induced reinstatement of cocaine seeking: MGluR, stress and cocaine]]></article-title>
<source><![CDATA[Addiction Biology]]></source>
<year>2012</year>
<volume>17</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>557-64</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miranda]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[J. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Cedillo]]></surname>
<given-names><![CDATA[L. N.]]></given-names>
</name>
<name>
<surname><![CDATA[Sandoval-Sánchez]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Millán-Mejía]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Castillo]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Velázquez-Martínez]]></surname>
<given-names><![CDATA[D. N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The GABA-B antagonist 2-hydroxysaclofen reverses the effects of baclofen on the discriminative stimulus effects of d-amphetamine in the conditioned taste aversion procedure]]></article-title>
<source><![CDATA[Pharmacology Biochemistry and Behavior]]></source>
<year>2009</year>
<volume>93</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>25-30</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Monn]]></surname>
<given-names><![CDATA[J. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Valli]]></surname>
<given-names><![CDATA[M. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[B. G.]]></given-names>
</name>
<name>
<surname><![CDATA[Salhoff]]></surname>
<given-names><![CDATA[C. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Wright]]></surname>
<given-names><![CDATA[R. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Howe]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Bond]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Lodge]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Spangle]]></surname>
<given-names><![CDATA[L. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Paschal]]></surname>
<given-names><![CDATA[J. W.]]></given-names>
</name>
<name>
<surname><![CDATA[Campbell]]></surname>
<given-names><![CDATA[J. B.]]></given-names>
</name>
<name>
<surname><![CDATA[Griffey]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Tizzano]]></surname>
<given-names><![CDATA[J. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Schoepp]]></surname>
<given-names><![CDATA[D. D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Synthesis of the Four Isomers of 4-Aminopyrrolidine-2,4-dicarboxylate: Identification of a Potent, Highly Selective, and Systemically-Active Agonist for Metabotropic Glutamate Receptors Negatively Coupled to Adenylate Cyclase]]></article-title>
<source><![CDATA[Journal of Medicinal Chemistry]]></source>
<year>1996</year>
<volume>39</volume>
<numero>15</numero>
<issue>15</issue>
<page-range>2990-3000</page-range></nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moussawi]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Kalivas]]></surname>
<given-names><![CDATA[P. W.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction]]></article-title>
<source><![CDATA[European Journal of Pharmacology]]></source>
<year>2010</year>
<volume>639</volume>
<numero>1-3</numero>
<issue>1-3</issue>
<page-range>115-22</page-range></nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Peters]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Kalivas]]></surname>
<given-names><![CDATA[P. W.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine- and food-seeking behavior in rats]]></article-title>
<source><![CDATA[Psychopharmacology]]></source>
<year>2006</year>
<volume>186</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>143-9</page-range></nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Riley]]></surname>
<given-names><![CDATA[A. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Clasen]]></surname>
<given-names><![CDATA[M. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Friar]]></surname>
<given-names><![CDATA[M. A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Conditioned Taste Avoidance Drug Discrimination Procedure: Assessments and Applications]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Porter]]></surname>
<given-names><![CDATA[J. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Prus]]></surname>
<given-names><![CDATA[A. J.]]></given-names>
</name>
</person-group>
<source><![CDATA[The Behavioral Neuroscience of Drug Discrimination]]></source>
<year>2016</year>
<volume>39</volume>
<page-range>297-317</page-range><publisher-name><![CDATA[Springer International Publishing]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rothman]]></surname>
<given-names><![CDATA[R. B.]]></given-names>
</name>
<name>
<surname><![CDATA[Baumann]]></surname>
<given-names><![CDATA[M. H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Monoamine transporters and psychostimulant drugs]]></article-title>
<source><![CDATA[European Journal of Pharmacology]]></source>
<year>2003</year>
<volume>479</volume>
<numero>1-3</numero>
<issue>1-3</issue>
<page-range>23-40</page-range></nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sandoval-Sánchez]]></surname>
<given-names><![CDATA[A. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Cedillo Zavaleta]]></surname>
<given-names><![CDATA[L. N.]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[J. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Ruíz-García]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Miranda]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Administration of low doses of the 5-HT1A receptor agonist 8-OH-DPAT attenuates the discriminative signal of amphetamine in the conditioned taste aversion procedure]]></article-title>
<source><![CDATA[Pharmacology Biochemistry and Behavior]]></source>
<year>2020</year>
<volume>193</volume>
<page-range>172932</page-range></nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sandoval-Sánchez]]></surname>
<given-names><![CDATA[A. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[J. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Velázquez-Martínez]]></surname>
<given-names><![CDATA[D. N.]]></given-names>
</name>
<name>
<surname><![CDATA[Miranda]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La administración del antagonista GABAA bicuculina previene los efectos de la administración del agonista 5-HT1A 8-OH-DPAT en las propiedades discriminativas de la anfetamina]]></article-title>
<source><![CDATA[Acta de Investigación Psicológica]]></source>
<year>2016</year>
<volume>6</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>2440-9</page-range></nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scofield]]></surname>
<given-names><![CDATA[M. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Heinsbroek]]></surname>
<given-names><![CDATA[J. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Gipson]]></surname>
<given-names><![CDATA[C. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Kupchik]]></surname>
<given-names><![CDATA[Y. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Spencer]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[A. C. W.]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts-Wolfe]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Kalivas]]></surname>
<given-names><![CDATA[P. W.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis]]></article-title>
<source><![CDATA[Pharmacological Reviews]]></source>
<year>2016</year>
<volume>68</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>816-71</page-range></nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Dayas]]></surname>
<given-names><![CDATA[C. V.]]></given-names>
</name>
<name>
<surname><![CDATA[Aujla]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Baptista]]></surname>
<given-names><![CDATA[M. A. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Martin-Fardon]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Weiss]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Activation of Group II Metabotropic Glutamate Receptors Attenuates Both Stress and Cue-Induced Ethanol-Seeking and Modulates c-fos Expression in the Hippocampus and Amygdala]]></article-title>
<source><![CDATA[Journal of Neuroscience]]></source>
<year>2006</year>
<volume>26</volume>
<numero>39</numero>
<issue>39</issue>
<page-range>9967-74</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
